Product Description: Clavulanic acid is a naturally occurring powerful bacterial β-lactamases inhibitor for research of infections caused by bacteria, including infections of the ears. Clavulanic acid is active against a wide spectrum of gram-positive and gram-negative bacterias[1].
Applications: COVID-19-immunoregulation
Formula: C8H9NO5
Citations: Eur J Pharmacol. 2024 Sep 28:177017./Genomics. 2022: 110527./Int J Mol Sci. 2023 Oct 27, 24(21), 15657./Biomed Res Int. 2018 Jul 2;2018:3579832. /bioRxiv. 2024 May 10./Nat Commun. 2022 Mar 2;13(1):1116.
References: [1]Parag S Saudagar, et al. Clavulanic acid: a review. Biotechnol Adv. Jul-Aug 2008;26(4):335-51/[2]Neu HC, et al. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978 Nov;14(5):650-5./[3]Beceiro A,et al. In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii. Antimicrob Agents Chemother. 2009 Oct;53(10):4298-304./[4]Soyocak A, et al. Tannic acid exhibits anti-inflammatory effects on formalin-induced paw edema model of inflammation in rats. Hum Exp Toxicol. 2019 Nov;38(11):1296-1301.
CAS Number: 58001-44-8
Molecular Weight: 199.162
Compound Purity: 99.76
Research Area: Infection; Inflammation/Immunology
Solubility: DMSO : 13.89 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : 7 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Antibiotic;Bacterial;Beta-lactamase
English
Deutsch
